To analyze the effect of this compound on the progression of malignant disease, we employed orthotopic and heterotopic syngeneic models of 4T1 breast cancer in mice exhibiting a robust expression of uPA and PAI‐1 in the tumors. The gene discussed is PLAU; the disease is breast carcinoma.